One month of oral galactose treatment initiated immediately after the STZ-icv administration , successfully prevented development of the STZ-icv-induced cognitive deficits .
O O O O B-ChemicalEntity O O O O O B-ChemicalEntity O O O O O O O B-ChemicalEntity B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O